Cole G Bradley
SEC Form 4 insider trading activity
Cole G Bradley has filed 4 SEC Form 4 filings (7 transaction rows) across 2 companies, including KNSA, CSTL, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: Jul 31, 2026.
On the most recent filing, Cole G Bradley is listed as Director at Kiniksa Pharmaceuticals International, plc. Inside the rolling window, Cole G Bradley reported no open-market purchases and 2 open-market sales totaling $510K in KNSA and CSTL. The largest disclosed transaction in the window is a sale of 3,673 KNSA shares on Jul 29, 2026, worth $299K.
Companies traded
Other insiders at KNSA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$510K
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Cole G Bradley made?
Cole G Bradley has filed 4 SEC Form 4 filings (7 transaction rows) across 2 companies, including KNSA, CSTL since 2026.
Which companies does Cole G Bradley trade?
Cole G Bradley has filed SEC Form 4 disclosures for 2 companies, including KNSA, CSTL.
When was Cole G Bradley's most recent SEC Form 4 filing?
Cole G Bradley's most recent SEC Form 4 filing on Tracefour is dated Jul 31, 2026.
What is Cole G Bradley's total buy and sell value in the current window?
Inside the rolling retention window, Cole G Bradley bought $0 and sold $510K based on SEC Form 4 filings.
What was Cole G Bradley's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 3,673 KNSA shares on 2026-07-29, worth $299K, per SEC Form 4 filings.